AOA presses for FDA enforcement focused on ‘Eyebot’ Kiosk

Published on March 25, 2026
Detailed legal complaint documents patient safety, health and product claim concerns—and seeks immediate federal agency enforcement action.
Continue reading on website
Other news

LENZ Therapeutics Reports Fourth Quarter, Full-Year Financial Results as Sales of Presbyopia Drop Gain Momentum

March 25, 2026
SAN DIEGO—LENZ Therapeutics, Inc. (Nasdaq: LENZ), a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44%, yesterday reported financial results for the fourth quarter and full year ended December 31, 2025 and provided a corporate update. Approved by the FDA in July 2025, VIZZ is a once-daily aceclidine-based eye drop for the treatment of age-related

Kentucky optometry board faces pushback on proposed reforms

March 25, 2026
Kentucky’s optometry board is trying to address a scandal after years of issuing waivers for optometry graduates who couldn’t pass their national exams.